Literature DB >> 25250201

Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.

Nadia Anikeeva1, Yuri Sykulev1, Edward J Delikatny2, Anatoliy V Popov2.   

Abstract

Pyropheophorbide a (Pyro) is a near-infrared (NIR) fluorescent dye and photosensitizer with high quantum yield that makes the dye suitable for tumor treatment both as an imaging and therapy agent. We have designed and synthesized a series of a Pyro-based NIR probes, based on the conjugation of Pyro with lipids. The nature of our probes requires the use of a lipophilic carrier to deliver the probes to cancer cell membranes. To address this, we have utilized lipid-based nanoparticles (LNPs) consisting of PEGylated lipids, which form the nanoparticle shell, and a lipid core. To endow the LNPs with targeting properties, nitrilotriacetic acid (NTA) lipids were included in the composition that enables the non-covalent attachment of His-tag targeting proteins preserving their functional activity. We found that the nature of the core molecules influence the nanoparticle size, shelf-life and stability at physiological temperature. Two different Pyro-lipid conjugates were loaded either into the core or shell of the LNPs. The conjugates revealed differential ability to be accumulated in the cell membrane of the target cells with time. Thus, the modular organization of the core-shell LNPs allows facile adjustment of their composition with goal to fine tuning the nanoparticle properties for in vivo application.

Entities:  

Keywords:  Lipid-based nanoparticles; lipid-based fluorescent imaging agent; near-infrared fluorescent probes; pyropheophorbide a

Year:  2014        PMID: 25250201      PMCID: PMC4171838     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  69 in total

1.  Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties.

Authors:  Elena L Luzina; Anatoliy V Popov
Journal:  Eur J Med Chem       Date:  2012-03-23       Impact factor: 6.514

Review 2.  Lipid-core micelles for targeted drug delivery.

Authors:  Vladimir P Torchilin
Journal:  Curr Drug Deliv       Date:  2005-10       Impact factor: 2.565

3.  In vivo detection of phospholipase C by enzyme-activated near-infrared probes.

Authors:  Theresa M Mawn; Anatoliy V Popov; Nancy J Beardsley; Klara Stefflova; Matthew Milkevitch; Gang Zheng; E James Delikatny
Journal:  Bioconjug Chem       Date:  2011-11-29       Impact factor: 4.774

Review 4.  The dynamic regulation of integrin adhesiveness.

Authors:  M S Diamond; T A Springer
Journal:  Curr Biol       Date:  1994-06-01       Impact factor: 10.834

5.  Synthesis and characterization of fluorinated derivatives of cresolsulfonphthalein.

Authors:  Alexander V Kachur; Diana Sardelis; Catherine Bentzley; Anatoliy V Popov; E James Delikatny; Joel Karp
Journal:  J Fluor Chem       Date:  2013-01-01       Impact factor: 2.050

6.  Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes.

Authors:  Tatiana Lebedeva; Nadja Anikeeva; Spyros A Kalams; Bruce D Walker; Ibragim Gaidarov; James H Keen; Yuri Sykulev
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

7.  In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.

Authors:  Beena Ashok; Lise Arleth; Rex P Hjelm; Israel Rubinstein; Hayat Onyüksel
Journal:  J Pharm Sci       Date:  2004-10       Impact factor: 3.534

8.  Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging.

Authors:  Hongtao Chen; Sungwon Kim; Li Li; Shuyi Wang; Kinam Park; Ji-Xin Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

9.  Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?

Authors:  Nadia Anikeeva; Tatiana Mareeva; Wei Liu; Yuri Sykulev
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  6 in total

1.  Synthesis and Evaluation of Cytosolic Phospholipase A(2) Activatable Fluorophores for Cancer Imaging.

Authors:  Michael G Chiorazzo; Noah B Bloch; Anatoliy V Popov; Edward J Delikatny
Journal:  Bioconjug Chem       Date:  2015-10-28       Impact factor: 4.774

2.  Emerging applications of porphyrins in photomedicine.

Authors:  Haoyuan Huang; Wentao Song; James Rieffel; Jonathan F Lovell
Journal:  Front Phys       Date:  2015-04-10

3.  Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.

Authors:  Ketan Patel; Ravi Doddapaneni; Vasanthakumar Sekar; Nusrat Chowdhury; Mandip Singh
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

4.  A fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs.

Authors:  Felista L Tansi; Ronny Rüger; Ansgar M Kollmeier; Claudia Böhm; Roland E Kontermann; Ulf K Teichgraeber; Alfred Fahr; Ingrid Hilger
Journal:  BMC Biotechnol       Date:  2017-01-18       Impact factor: 2.563

5.  Nonprotecting Group Synthesis of a Phospholipase C Activatable Probe with an Azo-Free Quencher.

Authors:  Benjamin K Liebov; Alejandro D Arroyo; Natalia I Rubtsova; Sofya A Osharovich; E James Delikatny; Anatoliy V Popov
Journal:  ACS Omega       Date:  2018-06-25

6.  Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore.

Authors:  Michael G Chiorazzo; Hanna Maja Tunset; Anatoliy V Popov; Berit Johansen; Siver Moestue; E James Delikatny
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.